What Causes Erectile Dysfunction? Symptoms, Risk Factors, and Treatments Explained
Clara Hanson Smith
Erectile dysfunction (ED) is a common condition affecting over 50% of men between 40 and 70 in the UK…
Mounjaro 2025 Price Increase: What Changed and What It Costs Now
2 min read time
Content
Join our newsletter
Sign up to enjoy regular updates, exclusive promotions, and special offers.
The September 2025 increase has already taken effect. Here is what changed, what private patients pay now and whether prices have subsequently fallen.
Why did the price Increase?
When Eli Lilly first launched Mounjaro, the goal was to create an effective treatment for both type 2 diabetes and obesity.
To support early NHS access in the UK, the medication was initially priced significantly lower than in other countries. However, due to international pricing pressure (particularly from the United States), Eli Lilly is now adjusting prices to better align with global markets. This increase is intended to balance international and domestic cost.
How much did the price increase?
Eli Lilly increased the price by up to 170% to buy Mounjaro While the rise was slightly less steep for the lower doses, such as 2.5mg and 5mg, all strengths were affected by the new pricing.
At The Family Chemist we work hard to remain competitive and are direct discussions with manufacturers to secure the best possible pricing.
| Dose | Price |
|---|---|
| 2.5mg Starter Pack: Needles, Swabs & Sharpsbin | £174.99 |
| 2.5 mg | £164.99 |
| 5 mg | £178.99 |
| 7.5 mg | £234.99 |
| 10 mg | £258.99 |
| 12.5 mg | £278.99 |
| 15 mg | £293.99 |
| 2.5mg & 5mg Starter Pack | £344.99 |
| 2.5mg & 5mg & 7.5mg Starter Pack | £579.99 |
What did this mean for patients?
The price increase was unavoidable, and it meant higher monthly costs for patients.
This sudden rise understandably caused concern among long-term users who experienced positive results with the medication. Some reported feelings of frustration and anxiety, with many expressing concerns about being able to afford treatment in future.
Frequently asked questions
How we reviewed this article:
-
Current version
Share:
Blog suggestions
Orforglipron is a once-daily weight loss pill developed by Eli Lilly and marketed in the US as Foundayo. Unlike injectable GLP-1 treatments, it is taken by mouth without food or water restrictions. Here, we explain how orforglipron works, how effective
Orforglipron is a once-daily weight loss pill developed by Eli Lilly and marketed in the US as Foundayo. Unlike injectable GLP-1 treatments, it is taken by mouth without food or water restrictions. Here, we explain how orforglipron works, how effective
The Wegovy pill has been approved in the UK and is expected to become available through regulated providers from 1 July 2026. Learn who may be eligible, how to access it safely and what to expect from this once-daily weight
The Wegovy pill has been approved in the UK and is expected to become available through regulated providers from 1 July 2026. Learn who may be eligible, how to access it safely and what to expect from this once-daily weight
The Wegovy tablet is a once-daily weight loss pill containing semaglutide, offering an alternative to weekly injections. Discover how it works, how much weight people may lose, how it compares with injections and when it could become available in the
The Wegovy tablet is a once-daily weight loss pill containing semaglutide, offering an alternative to weekly injections. Discover how it works, how much weight people may lose, how it compares with injections and when it could become available in the
Related products
Read more about Weight Care
How To Reduce Side Effects Of Finasteride
Clara Hanson Smith
How to the reduce side effects of Finasteride Table of Contents Written by: The Family ChemistMedically reviewed by: Tannaz SohrabiPublished: 30/03/2026 What is Finasteride and how does it work? Finasteride is a commonly prescribed medication for male pattern baldness (androgenetic alopecia) and benign prostatic hyperplasia (BPH). Finasteride works by blocking the
Erectile Dysfunction: Causes and When To Get Treatment
Clara Hanson Smith
Erectile dysfunction (ED) is a common condition affecting over 50% of men between 40 and 70 in the UK…